Evidence map›Paper›PMID 42203860›Full record

ReviewNature methods2026

External validation improves generalizability, replicability and reproducibility in predictive models for neuroimaging.

Matthew Rosenblatt, Maya L Foster, Brendan D Adkinson, Link Tejavibulya, Milana Khaitova, Jean Ye, Huili Sun, Raimundo X Rodriguez, Chris C Camp, Ash Chinta and 5 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Matthew RosenblattDepartment of Biomedical Engineering, Yale University, New Haven, CT, USA. mjrosenblatt@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-3894-6198
Maya L FosterDepartment of Biomedical Engineering, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-1617-1811
Brendan D AdkinsonInterdepartmental Neuroscience Program, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-3196-8674
Link TejavibulyaInterdepartmental Neuroscience Program, Yale University, New Haven, CT, USA.
Milana KhaitovaDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
Jean YeInterdepartmental Neuroscience Program, Yale University, New Haven, CT, USA.
Huili SunDepartment of Biomedical Engineering, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-4851-3046
Raimundo X RodriguezInterdepartmental Neuroscience Program, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-4395-4501
Chris C CampInterdepartmental Neuroscience Program, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-2960-8872
Ash ChintaDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
Marie C McCuskerInterdepartmental Neuroscience Program, Yale University, New Haven, CT, USA.
Ling HanDepartment of Computer Science, Yale University, New Haven, CT, USA.
Christopher T FieldsDepartment of Psychiatry, Yale School of Medicine, New Haven, USA.
Saloni MehtaDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-1775-4776
Dustin ScheinostDepartment of Biomedical Engineering, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-6301-1167

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Medical Scientist Training ProgramT32GM136651 · NIGMS · YALE UNIVERSITY · PI BARBARA I KAZMIERCZAK · 2020 to 2026
$16.5M
An Individualized, Multidimensional Dimensional Approach to PsychopathologyR01MH121095 · NIMH · YALE UNIVERSITY · PI CONSTABLE, R TODD, SCHEINOST, DUSTIN · 2019 to 2023
$4.2M
Investigating neural and behavioral indications of persistent alcohol-related thoughtsF31AA032179 · NIAAA · YALE UNIVERSITY · PI Jean Ye · 2024 to 2026
$77k
National Science Foundation (NSF) DGE-2139841National Science Foundation (NSF) DGE2139841NCATS NIH HHS UL1 TR001863U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) 1U01HL150596U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI) 5T32HG010464-07U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) T32GM136651U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) 1F31MH136823U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH121095U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH126133-03U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA) F31AA032179U.S. Department of Health & Human Services | NIH | National Institute on Minority Health and Health Disparities (NIMHD) 1F30MD018941U.S. Department of Health & Human Services | NIH | National Institute on Minority Health and Health Disparities (NIMHD) 3R01MD018255
6 · The paper itself

Abstract

Poor generalizability continues to hinder mapping brain activity to behavior using human neuroimaging data. A potential solution is predictive modeling, which evaluates generalizability in unseen data from the same dataset. However, predictive models often fail external validation-a stricter test of generalizability involving evaluation in an independent dataset. In this Perspective, we explain how evaluating generalizability via external validation can improve replicability (illusory generalizability and bias) and reproducibility (data leakage and data manipulations). We also provide advice on statistical power, dataset shift and training models. A model's success in external validation provides evidence for its generalizability, but interpretations depend on the population characteristics of the training and external datasets. Even failed external validation constitutes an opportunity for scientific insight or methodological adjustments. Sharing data and models, combined with standalone external validation studies, will increase the prevalence of external validation. In turn, an increased focus on external validation can drive more generalizable, replicable and reproducible neuroimaging results.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.